Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Net Income (2018 - 2025)

Historic Net Income for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.0 million.

  • Precision Biosciences' Net Income fell 118.37% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 2935479.45%. This contributed to the annual value of -$18.8 million for FY2023, which is 5147.7% up from last year.
  • Precision Biosciences' Net Income amounted to -$20.0 million in Q3 2025, which was down 118.37% from -$21.1 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Net Income registered a high of $25.4 million during Q2 2024, and its lowest value of -$30.7 million during Q4 2021.
  • Its 5-year average for Net Income is -$11.3 million, with a median of -$11.6 million in 2021.
  • Examining YoY changes over the last 5 years, Precision Biosciences' Net Income showed a top increase of 38707.38% in 2024 and a maximum decrease of 73166.37% in 2024.
  • Quarter analysis of 5 years shows Precision Biosciences' Net Income stood at -$30.7 million in 2021, then soared by 70.5% to -$9.1 million in 2022, then skyrocketed by 68.49% to -$2.9 million in 2023, then crashed by 731.66% to -$23.7 million in 2024, then grew by 15.76% to -$20.0 million in 2025.
  • Its Net Income stands at -$20.0 million for Q3 2025, versus -$21.1 million for Q2 2025 and -$21.1 million for Q1 2025.